Duration of the anti-androgen in men undergoing six months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death.

被引：0
|
作者：
Sanford, Nina Niu
Chen, Ming-Hui
Loffredo, Marian J.
Renshaw, Andrew A.
Kantoff, Philip W.
D'Amico, Anthony Victor
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Univ Connecticut, Dept Stat, Storrs, CT USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Baptist Hosp Miami, Miami, FL USA
[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5070
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Low Testosterone at First Prostate-Specific Antigen Failure and Assessment of Risk of Death in Men With Unfavorable-Risk Prostate Cancer Treated on Prospective Clinical Trials
    Atkins, Katelyn M.
    Chen, Ming-Hui
    Wu, Jing
    Renshaw, Andrew A.
    Loffredo, Marian
    Kantoff, Philip W.
    Small, Eric J.
    D'Amico, Anthony V.
    CANCER, 2018, 124 (07) : 1383 - 1390
  • [32] Duration of Androgen Deprivation Combined With Radiation Therapy Does Not Jeopardize Time to Castration Resistance in Men With Unfavorable Intermediate- and High-Risk Prostate Cancer
    Crehange, G.
    Gauthier, M.
    Ladoire, S.
    Mirjolet, C.
    Cormier, L.
    Khoury, C.
    Truc, G.
    Peignaux-Casasnovas, K.
    Martin, E.
    Maingon, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S408 - S408
  • [33] Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable intermediate- and high-risk prostate cancer.
    Dyer, Michael A.
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian Joseph
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [34] Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy A Secondary Analysis of a Randomized Clinical Trial
    Royce, Trevor J.
    Chen, Ming-Hui
    Wu, Jing
    Loffredo, Marian
    Renshaw, Andrew A.
    Kantoff, PhilipW.
    D'Amico, Anthony V.
    JAMA ONCOLOGY, 2017, 3 (05) : 652 - 658
  • [35] Androgen deprivation therapy use and risk of death in men treated with high-dose radiation for intermediate-risk prostate cancer
    Keane, Florence K.
    D'Amico, Anthony V.
    CANCER, 2016, 122 (15) : 2296 - 2298
  • [36] Comorbidity and the risk of all-cause and prostate cancer-specific mortality in men with unfavorable risk prostate cancer undergoing high dose radiation therapy alone.
    Mai Anh Huynh
    Chen, Ming-Hui
    Wu, Jing
    Braccioforte, Michelle H.
    Moran, Brian Joseph
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [37] Molecular features of complete response to neoadjuvant anti-androgen therapy in high risk localized prostate cancer
    Tewari, Alok
    Cheung, Alexander T.
    Conway, Jake
    Park, Jihye
    Wankowicz, Stephanie
    Lis, Rosina T.
    Zhang, Zhenwei
    AlDubayan, Saud
    McKay, Rana R.
    Taplin, Mary-Ellen
    Van Allen, Eliezer M.
    CANCER RESEARCH, 2020, 80 (16)
  • [38] Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
    Crawley, Danielle
    Garmo, Hans
    Rudman, Sarah
    Stattin, Par
    Haggstrom, Christel
    Zethelius, Bjorn
    Holmberg, Lars
    Adolfsson, Jan
    Van Hemelrijck, Mieke
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (12) : 2698 - 2704
  • [39] Impact of Concurrent Androgen-Deprivation Therapy and Radiation Therapy Versus Radiation Therapy Alone on Overall Survival for Men With Unfavorable Intermediate-Risk Prostate Cancer
    Johnson, S. B.
    Lester-Coll, N. H.
    Stahl, J. M.
    Nath, S. K.
    Yu, J. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E240 - E240
  • [40] Re: Surrogate End Points for All-Cause Mortality in Men with Localized Unfavorable-Risk Prostate Cancer Treated with Radiation Therapy vs Radiation Therapy plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 199 (01): : 28 - 28
12345